Efficacy and Safety of Idelalisib in Combination With Ofatumumab for Previously Treated Chronic Lymphocytic Leukemia
Clinical trial NCT01659021 · TERMINATED
Trial details
- NCT number
- NCT01659021
- Sponsor
- Gilead Sciences
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-04
- Primary completion
- 2018-08-15
- Enrollment
- 261
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.